Home News & Events Press releases Press releases Category AcquisitionsAwardsCorporate earningsESGInvestor conferencesLeadershipTechnologyWhitepaper Year 20252024202320222021202020192018201720162015 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media What’s happening in ICON ICON Plc Innovation is accelerating progress in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions bring together advanced formulation design, real-time dose flexibility, and world-class CMC expertise to si... 19h 1 View post View webpage ICON Plc ICON is proud to be recognised among the top global companies in the world for female employees. As of 31 December 2024, women make up 70% of our workforce and hold 60% of director-level and above roles—a powerful refle... 20h View post View webpage ICON Plc With PubsHub Journals & Congresses, you’ll receive real-time alerts for updates, extensions, and changes to deadlines on your personalized watch list. That means fewer surprises - and better decisions. See how easy it is... 21h 2 View post View webpage ICON Plc Data is the foundation of every decision in clinical development, yet the journey from first patient interaction to final submission is rarely seen in full. Our latest blog takes you behind the scenes to explore how inf... 23h 2 View post View webpage ICON Plc Central laboratories are under more pressure than ever. Increasingly complex protocols, frequent amendments, and growing data demands require speed, agility, and uncompromising scientific integrity. At ICON Laboratories,... 23h View post View webpage ICON Plc While multi-pronged global health efforts are essential to combatting HIV, systemic impediments persist. In ICON’s article, learn how drug developers can play a role in reshaping the future of HIV control, and what they ... 11 Dec View post View webpage ICON Plc Traditional trial settings often fail to reveal the added value of emerging HIV therapies. Explore how developers can plan trials that demonstrate the true advantages and utility of an HIV intervention in the article fro... 11 Dec 1 View post View webpage ICON Plc What should you consider when choosing a training dataset for your AI-enabled SaMD? Our whitepaper has the answers. Learn about AI models and data best practices and plan for your FDA Pre-Sub. Download it today. https://... 11 Dec 1 View post View webpage ICON Plc Learn the pros and cons of different AI models for SaMDs. The right model and data training sets are essential to develop your AI-enabled device. Our latest whitepaper lays out the best practices for data and AI models... 11 Dec View post View webpage ICON Plc Today marked the conclusion of #SCDM Japan in Tokyo, an event dedicated to advancing excellence in clinical data management. Over the past days, industry leaders and professionals came together to explore key topics such... 11 Dec View post View webpage ICON Plc From exhaustive site visits to intelligent oversight, CRA responsibilities are evolving. ICON’s latest insights in Pharma Times reveal why digital literacy, data interpretation and strategic thinking are now essential sk... 10 Dec View post View webpage ICON Plc CRAs are at the centre of clinical trial evolution. Risk-based monitoring, intelligent oversight tools and AI are changing how trials are managed. ICON explores what this means for the future in Pharma Times: https://ow.... 10 Dec 6 View post View webpage
